Clinical Trials
19 trialsNCT05831787 2026-05-18
COSMIC
ASH Research Collaborative
Completed
NCT07450833 2026-04-20
BOOST
Benfovir AG
Phase 1 Completed
NCT05119855 2026-02-05
Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT04341012 2026-01-26
Breath Analysis Based Disease Biomarkers
Mayo Clinic
Completed
NCT04872738 2026-01-06
LymphVAX
Massachusetts General Hospital
Completed
NCT04421625 2025-12-30
PAPESCO-19
Institut Cancerologie de l'Ouest
Phase NA Completed
NCT04427280 2025-09-04
CARDS
Royal Marsden NHS Foundation Trust
Completed
NCT04761822 2025-08-12
SARS
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2 Completed
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT04578132 2025-04-01
SOGUGCOVID
Spanish Oncology Genito-Urinary Group
Completed
NCT05386355 2025-03-11
MoVeUP
IDeA States Pediatric Clinical Trials Network
Phase NA Completed
NCT04683744 2025-01-31
Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation
Indiana University
Completed
NCT04466098 2025-01-29
Multiple Dosing of Mesenchymal Stromal Cells in Patients With ARDS (COVID-19)
Masonic Cancer Center, University of Minnesota
Phase 2 Completed
NCT06469138 2025-01-29
8479217
BerGenBio ASA
Phase 1 Completed
NCT05148806 2024-12-09
MELODY
Imperial College London
Completed
NCT04358406 2023-11-28
Rhu-pGSN for Severe Covid-19 Pneumonia
BioAegis Therapeutics Inc.
Phase 2 Completed
NCT04397614 2023-04-24
Mobile Health Study and Enhanced Symptom Monitoring in COVID-19 Cancer Patients
University of Oklahoma
Phase NA Completed
NCT04548531 2023-02-22
Engaging Patients in Colon Cancer Screening Decisions During COVID-19
Massachusetts General Hospital
Phase NA Completed
NCT04446429 2021-12-10
Anti-Androgen Treatment for COVID-19
Applied Biology, Inc.
Phase NA Completed